Moderna Inc (MRNA) - Financial and Strategic SWOT Analysis Review

Moderna Inc (MRNA) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Moderna Inc (Moderna) is a biotechnology company that focuses on the development of messenger RNA (mRNA) therapeutics and vaccines. The company develops and discovers drugs that produce proteins or antibodies inside patient cells. Its pipeline includes various drug modalities such as prophylactic vaccines, therapeutic vaccines, intratumoral immuno-oncology, localized therapeutics, and liver intracellular. Moderna through its mRNA therapeutics platform develops and produces human proteins, antibodies, and novel proteins, which help in preventing, treating and curing diseases. It also develops therapeutics in the areas of infectious disease, rare liver disease, immuno-oncology, and cardiovascular disease. Moderna Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Moderna Inc Key Recent Developments

May 13,2024: Moderna to Present at Upcoming Conferences in May/June 2024
May 02,2024: Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Apr 25,2024: Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Mar 27,2024: Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Moderna Inc - Key Facts
Moderna Inc - Key Employees
Moderna Inc - Key Employee Biographies
Moderna Inc - Major Products and Services
Moderna Inc - History
Moderna Inc - Company Statement
Moderna Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Moderna Inc - Business Description
Other Break-up: Collaboration Revenue
Performance
Other Break-up: Grant Revenue
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Moderna Inc - Corporate Strategy
Moderna Inc - SWOT Analysis
SWOT Analysis - Overview
Moderna Inc - Strengths
Moderna Inc - Weaknesses
Moderna Inc - Opportunities
Moderna Inc - Threats
Moderna Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Moderna Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 13, 2024: Moderna to Present at Upcoming Conferences in May/June 2024
May 02, 2024: Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Apr 25, 2024: Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Mar 27, 2024: Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Feb 23, 2024: Government of Canada announces major milestone in the Canadian biomanufacturing sector
Feb 22, 2024: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Feb 22, 2024: Government of Canada To Announce Major Milestone Achieved in Canadian Biomanufacturing and Life Sciences Sector
Feb 07, 2024: Moderna, Inc. Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Feb 01, 2024: Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Dec 07, 2023: Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Moderna Inc, Key Facts
Moderna Inc, Key Employees
Moderna Inc, Key Employee Biographies
Moderna Inc, Major Products and Services
Moderna Inc, History
Moderna Inc, Subsidiaries
Moderna Inc, Key Competitors
Moderna Inc, Ratios based on current share price
Moderna Inc, Annual Ratios
Moderna Inc, Annual Ratios (Cont...1)
Moderna Inc, Annual Ratios (Cont...2)
Moderna Inc, Interim Ratios
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Moderna Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Moderna Inc, Performance Chart (2019 - 2023)
Moderna Inc, Ratio Charts
Moderna Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Moderna Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings